HOME >> BIOLOGY >> NEWS
DuPont to launch soybeans into space

CAPE CANAVERAL, Fla., May 29, 2002 In the first space experiment of its kind, DuPont tomorrow will begin space exploration designed to discover new scientific research about one of the most consumed crops in the world today soybeans.

Continuing its extensive history with NASA, DuPont has partnered with the Wisconsin Center for Space Automation and Robotics (WCSAR) -- a NASA Commercial Space Center at the University of Wisconsin-Madison -- to conduct an unprecedented exploration of soybean development by launching and growing soybean plants in space during NASAs space shuttle flight scheduled for takeoff Thursday, May 30.

The research will determine whether plants grow differently in space and examine the effects of zero-gravity on plant growth and development. The soybeans-in-space launch is the first initiative to grow a complete soybean crop in space -- from planting the seed to harvesting the grain. DuPont subsidiary, Pioneer Hi-Bred International, Inc., and WCSAR will study the harvested seed from soybean plants grown in space to find out if they have improved oil, protein, carbohydrates or secondary metabolites that could benefit farmers and consumers. According to the United Soybean Board, soybeans are the largest single source of protein meal and vegetable oil in the human diet. Domestically, soybeans provide 80 percent of the edible consumption of fats and oils in the United States. In 2000, 54 percent of the worlds soybean trade originated from the United States with soybean and product exports totaling more than $6.6 billion. The worlds largest seed company, Pioneer, is the brand leader in soybeans with more than 100 product varieties on the market.

As part of the initiative, scientists will plant Pioneer-brand soybean seeds in a specialized tray within a growth chamber developed by WCSAR. The chamber will be delivered to the International Space Station (ISS) from the space shuttle flight. Duri
'"/>

Contact: Anthony Farina
Anthony.R.Farina@usa.dupont.com
302-774-4114
DuPont
29-May-2002


Page: 1 2 3 4

Related biology news :

1. DuPont scientist named one of the worlds top young innovators by MITs Technology Review Magazine
2. DuPont introduces in-home personal protection from dangers of hurricanes
3. DuPont developing new protective suits for military, first responders
4. DuPont awarded highest US honor for technological innovation
5. President Bush to present DuPont with National Medal of Technology
6. DuPont to locate Asia Pacific R&D center in Shanghai
7. DuPont and NREL to develop worlds first integrated bio-refinery
8. DuPont receives US EPAs Presidential Green Chemistry Award for new innovation
9. DuPont launches high-tech medical fabrics to enhance protection for healthcare professionals
10. DuPont technology to receive US EPAs clean air excellence award
11. DuPont science leader discusses Sustainability and Integrated Science for the 21st Century

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DuPont launch soybeans into space

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: